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Abstract	  To	   study	   gene	   functions	   specifically	   in	   NKp46+	   cells	   we	   developed	   novel	   Cre	   mice	  allowing	  for	  conditional	  gene	  targeting	   in	  cells	  expressing	  Ncr1	   (encoding	  NKp46).	  We	  generated	  transgenic	  Ncr1greenCre	  mice	  carrying	  an	  EGFPcre	  fusion	  under	  the	  control	  of	  a	  proximal	   Ncr1	   promoter	   that	   faithfully	   directed	   EGFPcre	   expression	   to	   NKp46+	   cells	  from	  lymphoid	  and	  non-­‐lymphoid	  tissues.	  This	  approach	  allowed	  for	  direct	  detection	  of	  Cre-­‐expressing	  NKp46+	   cells	   via	   their	   GFP	   signature	   by	   flow	   cytometry	   and	   histology.	  Cre	   was	   functional	   as	   evidenced	   by	   the	   NKp46+	   cell-­‐specific	   expression	   of	   RFP	   in	  Ncr1greenCreROSA-­‐RFP	   reporter	   mice.	   We	   generated	   Ncr1greenCreIl2rgfl/fl	   mice	   that	   lack	  NKp46+	   cells	   in	   an	   otherwise	   intact	   hematopoietic	   environment.	   Il2rg	   encodes	   the	  common	  gamma	  chain	  (γc),	  which	  is	  an	  essential	  receptor	  subunit	  for	  cytokines	  (IL-­‐2,	  -­‐4,	  -­‐7,	   -­‐9,	   -­‐15,	   and	   -­‐21)	   that	   stimulate	   lymphocyte	   development	   and	   function.	   In	  Ncr1greenCreIl2rgfl/fl	  mice,	  NK	  cells	   are	   severely	   reduced	  and	   the	   few	  remaining	  NKp46+	  cells	  escaping	  γc	  deletion	  failed	  to	  express	  GFP.	  Using	  this	  new	  NK	  cell-­‐deficient	  model,	  we	   demonstrate	   that	   the	   homeostasis	   of	   NKp46+	   cells	   from	   all	   tissues	   (including	   the	  recently	  described	  intraepithelial	  ILC1	  subset)	  requires	  Il2rg.	  Finally,	  Ncr1greenCreIl2rgfl/fl	  mice	   are	   unable	   to	   reject	   B16	   lung	   metastases	   demonstrating	   the	   essential	   role	   of	  NKp46+	  cells	  in	  anti-­‐melanoma	  immune	  responses.	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Introduction	  	   NK	  cells	  belong	  to	  group	  1	  innate	  lymphocytes	  (ILCs),	  based	  on	  their	  expression	  of	  the	  transcription	  factor	  T-­‐bet	  and	  their	  ability	  to	  secrete	  the	  Th1	  cytokine	  IFN-­‐γ	  upon	  stimulation	  in	  vitro	  and	  in	  vivo	  and	  their	  capacity	  to	  promptly	  kill	  target	  cells	  (including	  tumors	   and	   infected	   cells)	   without	   prior	   sensitization	   [1][2,	   3].	   NK	   cells	   have	   been	  shown	   to	   participate	   in	   immune	   responses	   to	   various	  microbial	   pathogens,	   including	  viruses,	  bacteria,	   and	  parasites	   (reviewed	   in[4])	   through	  secretion	  of	   type	  1	  cytokines	  that	  recruit	  and	  activate	  hematopoietic	  effector	  cells.	  	  	   In	   the	   mouse,	   NK	   cells	   can	   be	   identified	   as	   CD3-­‐NKp46+	   cells	   that	   co-­‐express	  NK1.1	   on	   appropriate	   genetic	   backgrounds	   (including	   C57BL/6).	   NK	   cells	   do	   not	  represent	   a	   homogeneous	   cell	   population	   but	   can	   be	   phenotypically-­‐separated	   into	  several	  subpopulations.	  Commonly	  used	  cell	  surface	  markers	  include	  CD27	  and	  CD11b	  that	   divide	   NK	   cell	   populations	   into	   CD27+CD11b-­‐	   NK	   cells	   (representing	   the	   least	  differentiated	   cells)	   that	   give	   rise	   to	   CD27-­‐CD11b+	   NK	   cells	   via	   CD27+CD11b+	   NK	   cell	  intermediates	  [5][6].	  CD11b+	  NK	  cells	  can	  be	  further	  subdivided	  on	  the	  basis	  of	  KLRG1	  expression	  with	   KLRG1+	  marking	   terminally	   differentiated	  NK	   cells	   [7].	   NK	   cells	   have	  been	  detected	   in	   lymphoid	   tissues,	   including	  bone	  marrow	  (BM),	   spleen,	   lymph	  nodes	  (LNs),	   Peyer’s	   Patches,	   and	   thymus,	   but	   also	   in	   non-­‐lymphoid	   tissues,	   including	   liver,	  lungs,	  uterus,	  pancreas,	  skin,	  and	  intestine	  	  (reviewed	  in	  [8]).	  	   Many	  studies	  aiming	  at	  deciphering	  gene	  functions	  for	  NK	  cells	  make	  use	  of	  germ-­‐line	  gene	  targeted	  mice	  where	  all	  cells	  lack	  the	  gene	  in	  question.	  Given	  that	  the	  activity	  and	  differentiation	  of	  NK	  cells	  is	  intimately	  regulated	  by	  other	  immune	  cells	  (reviewed	  in	  [9],[10]),	  the	  consequences	  of	  gene	  deletions	  that	  intrinsically	  affect	  NK	  cells	  may	  be	  difficult	   to	   distinguish	   from	   indirect	   effects	   that	   occur	   in	   non-­‐NK	   cells.	   Furthermore,	  studying	   the	   role	   of	   NK	   cells	   in	   immune	   responses	   often	   involves	   the	   use	   of	   gene-­‐targeted	  mice	   lacking	   NK	   cells	   that	   also	   harbor	   other	   lymphoid	   defects	   (for	   example,	  Rag2-­‐/-­‐Il2rg-­‐/-­‐	  mice	  [11]	  or	  IL-­‐15-­‐/-­‐	  mice	  	  [12]),	  or	  depletion	  of	  NK	  cells	  using	  antibodies	  that	  are	  not	  NK	  cell	  specific,	  such	  as	  anti-­‐NK1.1	  (expressed	  by	  NKT	  cells)	  or	  anti-­‐asialo-­‐GM1	  (expressed	  by	  myeloid	  cells)	  [13],[14].	  	  	   In	   order	   to	   study	   gene	   functions	   specifically	   in	   NKp46+	   cells,	   we	   and	   others	  [15],[16]	  have	  created	  mice	  that	  allow	  for	  conditional	  gene	  targeting	  in	  Ncr1	  expressing	  cells	   using	   the	   Cre-­‐loxP	   system	   [17].	   To	   this	   end,	   we	   generated	   Ncr1greenCre	   mice	  expressing	  an	  EGFPcre	   fusion	  under	  the	  control	  of	  a	  proximal	  C57BL/6	  Ncr1	  promoter	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fragment.	   In	   Ncr1greenCre	   mice,	   GFP	   expression	   is	   restricted	   to	   NKp46+	   cells	   and	   Cre	  activity	   is	   regulated	   in	   an	   NKp46-­‐specific	   fashion.	   By	   crossing	   Ncr1greenCre	   to	   Il2rgfl/fl	  mice	   [18][19],	  we	  ablate	   the	  majority	  of	  NK	  cells	   from	  all	  organs	  and	  show	   that	   these	  mice	   are	   unable	   to	   reject	   B16	   melanoma	   cells	   in	   a	   lung	   metastasis	   model	   in	   vivo.	  Ncr1greenCre	  mice	  provide	  a	  new	  model	  to	  directly	  monitor	  NK	  cell-­‐specific	  Cre-­‐mediated	  gene	  ablation	  via	  GFP	  expression.	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Results	  
Generation	  of	  Ncr1greenCre	  mice	  	  	   Ncr1	   encodes	   the	   cell	   surface	   glycoprotein	  NKp46	   that	   is	   specifically	   expressed	  by	   NK	   cells	   [20],	   including	   classical	   and	   tissue-­‐resident	   NK	   cells[21]–[23],	   a	   recently	  identified	  novel	   lineage	  of	  non-­‐NK	   ILC1	   in	   the	  gut	   ([24],[25]),	  and	  a	  subset	  of	  group	  3	  ILCs	  [26]–[28].	  To	  further	  study	  gene	  function	  in	  NKp46+	  cells,	  we	  generated	  Ncr1greenCre	  transgenic	  mice	  expressing	  an	  EGFPcre	  fusion	  under	  the	  control	  of	  the	  proximal	  623bp-­‐fragment	  of	  the	  murine	  (C57BL/6)	  Ncr1	  promoter	  (Fig.	  1A).	  In	  this	  work,	  we	  identified	  NK	   cells	   as	   CD3-­‐CD19-­‐NK1.1+NKp46+	   cells,	   if	   not	   otherwise	   stated	   (see	   Supporting	  Information	  1A	  for	  the	  gating	  strategy	  used	  to	  detect	  NK	  cells).	  Ncr1greenCre-­‐derived	  NK	  cells	   from	   bone	  marrow	   (BM),	   spleen,	   liver,	   and	   lung	   expressed	   GFP	   at	   ranging	   from	  65%	  (BM)	  to	  85%	  (lungs)	  (Fig.	  1B	  and	  Supporting	  Information	  Fig.	  1B).	  NK	  cells	  are	  also	  present	   in	  non-­‐lymphoid	   tissues,	   including	   liver	   and	   lungs,	   but	   also	  pancreas,	   salivary	  glands,	   skin,	   and	   intestine	   (reviewed	   in	   [8]).	   Our	   analyses	   revealed	   that	   liver,	   lungs,	  pancreas,	   skin,	   small	   intestinal	   (SI)	   lamina	  propria	   lymphocytes	   (LPL),	   colonic	   LPL,	   SI	  intraepithelial	  lymphocytes	  (IELs),	  and	  colonic	  IEL	  harbored	  NK	  cells	  expressing	  GFP	  at	  similar	   frequencies	   than	   those	   from	   lymphoid	   organs,	   including	   BM,	   thymus,	   LN,	  mesenteric	  LN,	  cervical	  LN,	  spleen,	  and	  Peyer’s	  Patches	  (Fig.	  1C).	  NK	  cells	  from	  salivary	  glands	   contained	   the	   lowest	   frequencies	   of	  GFP	   expressing	  NK	   cells	   (Fig.	   1C)	   but	   also	  expressed	   lower	   levels	   of	   NKp46	   (Supporting	   Information	   Fig.	   1C).	   In	   the	   gut,	   we	  detected	  high	  levels	  of	  GFP	  expression	  in	  NKp46+	  cells	  including	  NK	  cells	  and	  NCR+	  ILC3	  (Fig.	  1D).	  GFP	  expression	  in	  Ncr1greenCre	  mice	  was	  restricted	  to	  NKp46+	  cells	  in	  all	  organs	  analyzed;	  T	   cells,	  B	   cells,	  DC,	   and	  other	  myeloid	   cells	  were	  GFP-­‐	   (Fig.	   1E	   and	  data	  not	  shown).	   These	   data	   illustrate	   that	   GFP	   expression	   is	   restricted	   to	   NKp46+	   cells	   from	  lymphoid	  and	  non-­‐lymphoid	  organs	  in	  Ncr1greenCre	  mice.	  
	  
Characterization	  of	  NK	  cells	  from	  Ncr1greenCre	  mice	  	   We	   next	   compared	   Ncr1greenCre	   to	   the	   previously	   published	   Ncr1GFP/+	   knock-­‐in	  mice	   [29]	   in	  order	   to	   further	  validate	   the	  minimal	  Ncr1	  promoter	   in	  Ncr1greenCre	  mice.	  We	   were	   specifically	   interested	   in	   the	   onset	   of	   GFP	   expression,	   its	   expression	   in	   NK	  subsets,	   and	   its	   expression	   by	   tissue-­‐resident	   NK	   cells.	   In	   the	   bone	   marrow,	   the	  expression	   of	   NKp46	   becomes	   detectable	   at	   the	   stage	   of	   immature	   NK	   cells	   (iNK)	  defined	   as	   Lin-­‐CD122+DX5-­‐NK1.1+	   cells	   in	   the	   bone	  marrow	   [30].	   In	   our	   analyses	   we	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found	   that	  40.6%	  (±18.9%)	  of	   iNK	   from	  Ncr1GFP/+	   knock-­‐in	   and	  39%	  (±15.6%)	  of	   iNK	  from	  Ncr1greenCre	  mice	   expressed	   GFP	   (Fig.	   2A).	   GFP+	   as	  well	   as	   GFP-­‐	   iNK	   cells	   lacked	  expression	   of	   CD11b	   (data	   not	   shown).	  Moreover,	  mature	  NK	   cells	   of	   Ncr1greenCre	   and	  Ncr1GFP/+	  mice	  harbored	   similar	   frequencies	  of	  GFP+	   cells	   (Fig.	  2A	  and	  B).	  Histological	  analyses	  of	  LNs	  from	  Ncr1greenCre	  mice	  revealed	  a	  similar	  distribution	  of	  GFP+	  NK	  cells	  in	  these	   tissues	   compared	   to	  Ncr1GFP/+	   control	  mice	   (Supporting	   Information	   Fig.	   2).	  We	  then	   compared	   the	   phenotype	   and	   function	   of	  GFP+	  NK	   cells	   from	  Ncr1greenCre	  mice	   to	  those	  from	  Ncr1GFP/+	  mice	  and	  to	  NK	  cells	  from	  C57BL/6	  mice.	  We	  found	  no	  significant	  differences	   in	  NK	  cell	   subset	  distribution	  defined	  by	  CD27	  and	  CD11b	  (Fig.	  2C),	   in	   the	  expression	   patterns	   for	   CD94,	   Ly49	   A,	   C/I,	   G2,	   H,	   D	   (Fig.	   2D),	   and	  NKG2D	   (MFI	   -­‐	   B6:	  399±55,	   Ncr1GFP/+:	   414±36,	   Ncr1greenCre:	   430±24).	   And	   in	   NK	   cell	   numbers	   (Fig.	   2E)	  under	  steady-­‐state	  conditions,	  or	  in	  NK	  cell	  IFN-­‐γ	  production	  (Fig.	  2F,	  left)	  or	  granzyme	  B	  expression	   (Fig.	   2F,	   right)	   after	   stimulation	   in	   vitro.	  Thus,	  NK	   cells	   from	  Ncr1greenCre	  mice	  appear	  phenotypically	  and	  functionally	  indistinguishable	  from	  wild-­‐type	  NK	  cells.	  	   	  
Cre-­‐recombinase	  is	  functional	  in	  NK	  cells	  in	  Ncr1greenCre	  mice	  	   In	   order	   to	   test	   Cre-­‐recombinase	   activity,	  we	   crossed	  Ncr1greenCre	  mice	   to	  Rosa-­‐dtRFP	  Cre-­‐reporter	  mice	  [31].	  These	  mice	  harbor	  a	  RFP	  transgene	  in	  the	  Rosa26	  locus,	  the	   expression	   of	  which	   is	   inhibited	   by	   a	   loxP-­‐flanked	   stop-­‐cassette	   preceding	   the	   rfp	  gene	  [31].	  Upon	  Cre-­‐mediated	  excision	  of	  the	  stop	  cassette,	  rfp	   is	  expressed,	  which	  can	  be	  monitored	  by	  FACS.	  Our	  analyses	  revealed	   that	  NKp46+	  cells	   from	  Ncr1greenCreRosa-­‐dtRFP	   mice	   expressed	   high	   levels	   of	   RFP	   (Fig.	   3A)	   and	   that	   RFP	   expression	   was	  restricted	  to	  NKp46+	  cells	  (Fig.	  3B).	  Moreover,	  essentially	  all	  GFP+	  cells	  expressed	  RFP	  (Supporting	  Information	  Fig.	  3).	  Other	  cells,	  including	  T	  cells,	  B	  cells,	  NKT	  cells,	  and	  DC,	  did	   not	   express	   RFP	   (Fig.	   3C).	   These	   results	   demonstrate	   that	   Cre	   is	   functional	   in	  Ncr1greenCre	  mice	  and	  its	  activity	  is	  restricted	  to	  NKp46+	  cells.	  	  	  
Ablation	  of	  NK	  cells	  by	  generating	  Ncr1greenCreIl2rgfl/fl	  mice	  	   To	  create	  a	  novel	  model	  specifically	  lacking	  NKp46+	  cells,	  we	  crossed	  Ncr1greenCre	  mice	  with	  Il2rgfl/fl	  mice	  bearing	  a	  floxed	  allele	  encoding	  the	  common	  cytokine	  receptor	  gamma	  chain	  (γc).	  γc	  is	  an	  essential	  subunit	  of	  the	  receptors	  for	  the	  cytokines	  IL-­‐2,	  -­‐4,	  -­‐7,	  -­‐9,	   -­‐15,	  and	   -­‐21	   [32]	   that	  act	  as	  critical	  survival	  and	  proliferation	   factors	   for	   lymphoid	  precursors	  and	  mature	  lymphocytes.	  We	  had	  previously	  shown	  that	  conditional	  ablation	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of	   Il2rg	   from	  mature	  NK	   cells	   resulted	   in	   the	   rapid	  disappearance	   of	   γc-­‐deficient	   cells	  [18]	  underscoring	  the	  essential	  role	  for	  Il2rg-­‐dependent	  cytokines	  (especially	  IL-­‐15)	  for	  NK	  cell	  homeostasis	   [33]–[35].	  The	   constitutive	  deletion	  of	   Il2rg	   in	  NKp46+	   cells	   from	  Ncr1greenCreIl2rgfl/fl	   mice	   resulted	   in	   an	   85%	   reduction	   of	   total	   NK	   cells	   from	  multiple	  lymphoid	   and	   non-­‐lymphoid	   tissues	   analyzed	   including	   epithelia	   from	   small	   intestine	  (Fig.	   4A).	   This	   reduction	   is	   similar	   to	   the	   frequencies	   of	   RFP+	   cells	   observed	   in	  Ncr1greenCreRosa-­‐RFP	  mice	  suggesting	  that	  the	  different	  floxed	  target	  genes	  were	  deleted	  with	   similar	   efficiency	   (Fig.	   4A).	  Along	   these	   lines,	  we	  did	  not	  detect	  GFP+	  NK	   cells	   in	  Ncr1greenCreIl2rgfl/fl	   mice	   suggesting	   that	   the	   residual	   NK	   cells	   did	   not	   express	   the	  
EGFPcre	   fusion	   protein	   (Fig.	   4B).	   Indeed,	   the	   few	   remaining	   NK	   cells	   in	  Ncr1greenCreIl2rgfl/fl	   mice	   expressed	   γc	   protein	   (Fig.	   4C).	   These	   GFP-­‐negative	   γc+	   cells	  displayed	   similar	   frequencies	   of	   CD27+CD11b-­‐,	   CD27+CD11b+,	   and	   CD27-­‐CD11b+	   cells	  than	   GFP+	   and	   GFP-­‐	   NK	   cells	   from	   Ncr1greenCre	   mice	   (Fig.	   4D)	   and	   displayed	   a	   similar	  capacity	  to	  elaborate	  IFN-­‐γ	  and	  granzyme	  B	  upon	  stimulation	  in	  vitro	  than	  controls	  (Fig.	  4E).	  Thus,	   the	   few	   remaining	  GFP-­‐	  NK	   cells	   in	  Ncr1greenCreIl2rgfl/fl	  mice	   resembled	   fully	  differentiated	  NK	  cells.	  	  NKp46+	  ILC3	   in	   the	  small	   intestines	  were	  reduced	  almost	  10-­‐times	  (Ncr1greenCre:	  3.2x104±1.9x104,	  Ncr1greenCreIl2rgfl/fl	  3.7x103±8.4x102;	  p<0,05),	  while	  T	  and	  B	  cells	  were	  normally	  represented	  in	  various	  organs	  of	  Ncr1greenCreIl2rgfl/fl	  mice,	  including	  BM,	  spleen,	  LN,	  liver,	  and	  lungs	  (Supporting	  Information	  Fig.	  4).	  	  	  We	   next	   compared	   genetic	   ablation	   versus	   antibody-­‐mediated	   deletion	   of	   NK	  cells.	   To	   this	   end	   we	   injected	   i.p.	   50µg	   of	   anti-­‐NK1.1	   antibodies	   (clone	   PK136)	   into	  C57BL/6	  mice	  and	  analyzed	   the	  mice	   two	  days	   later.	  We	   found	   that	  splenic	  as	  well	  as	  liver	   NK	   cells	   (identified	   as	   CD3-­‐CD19-­‐NKp46+CD122+	   cells)	   were	   efficiently	   deleted	  (around	  95%	  reduction	  compared	  to	  control	  B6	  mice)	  while	  NK	  cells	  from	  the	  BM	  were	  reduced	  by	  80%.	   Importantly,	  we	   found	   that	  NKT	  cells	   (identified	  as	  CD19-­‐CD3+CD1d-­‐PBS57	  tetramer+	  cells)	  were	  reduced	  in	  spleens	  (by	  around	  35%)	  and	  livers	  (by	  around	  85%)	  of	  the	  anti-­‐NK1.1	  treated	  mice	  (Supporting	  Information	  Fig.	  5).	  	  Together,	  these	  data	  suggest	  that	  Cre	  is	  active	  in	  most	  NKp46	  cells	  and	  NK	  cell-­‐specific	  γc	  deletion	  can	  be	  used	  to	  selectively	  eliminate	  the	  vast	  majority	  of	  NKp46+	  cells.	  In	  contrast,	  anti-­‐NK1.1	  antibodies	  result	  in	  a	  similar	  systemic	  NK	  cell	  depletion,	  however,	  also	  depletes	  NKT	  cells,	  which	  can	  be	  substantial	  depending	  on	  the	  target	  organ.	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Anti-­‐tumor	  responses	  in	  Ncr1greenCre	  Il2rgfl/fl	  mice	  	   We	  next	  challenged	  Ncr1greenCreIl2rgfl/fl	  mice	  with	  B16	  melanoma	  cells	  expressing	  luciferase	  (B16F10-­‐luc2+).	  This	  allowed	  us	  to	  analyze	  the	  effects	  of	  NK	  cell	  depletion	  on	  the	  kinetics	  of	   the	   tumor	   formation	   in	  mice	   in	  a	  non-­‐invasive	   fashion.	  The	   tumor	  cells	  were	  injected	  intravenously	  and	  the	  bioluminescence	  quantified	  3,	  7,	  and	  10	  days	  later.	  We	  injected	  Ncr1greenCre,	  Ncr1greenCreIl2rgfl/fl,	  as	  well	  as	  IL-­‐15-­‐/-­‐	  mice	  as	  controls.	  At	  day	  3,	  we	   detected	   pulmonary	   tumors	   in	   Ncr1greenCreIl2rgfl/fl	   as	   well	   as	   IL-­‐15-­‐/-­‐,	   but	   not	  Ncr1greenCre	  mice	  (Fig.	  5A,	  top	  row).	  Those	  tumors	  had	  increased	  in	  size	  until	  day	  7	  (Fig.	  5A,	  middle	  row).	  At	   this	   time	  point,	  we	  could	  also	  detect	  small	   tumors	   in	  control	  mice	  (Fig.	   5A,	   middle	   row),	   yet	   they	   were	   significantly	   smaller	   than	   those	   from	  Ncr1greenCreIl2rgfl/fl	  or	  IL-­‐15-­‐/-­‐	  mice.	  This	  was	  also	  true	  when	  we	  sacrificed	  the	  mice	  at	  day	  10	  and	  measured	   tumor	  cell	  burden	   in	   the	  explanted	   lungs	   (Fig.	  5A,	  bottom	  diagram).	  We	   found	   a	   higher	   tumor	   load	   in	   IL-­‐15-­‐/-­‐	   compared	   to	   Ncr1greenCreIl2rgfl/fl	   mice.	   This	  difference	  was	  significant	  at	  day	  3	  and	  day	  10	  (Fig.	  5A,	  bottom	  diagram).	  The	  observed	  differences	  in	  tumor	  load	  inversely	  correlated	  with	  the	  small	  numbers	  of	  remaining	  NK	  cells	  in	  the	  lungs	  of	  these	  mice.	  As	  such,	  IL-­‐15-­‐/-­‐	  mice	  had	  less	  pulmonary	  NK	  cells	  at	  day	  10	  than	  Ncr1greenCreIl2rgfl/fl	  mice	  but	  a	  higher	  tumor	  load	  (Fig.	  5A	  and	  B).	  Interestingly,	   we	   detected	   more	   T	   cells	   in	   the	   lungs	   of	   tumor-­‐bearing	  Ncr1greenCreIl2rgfl/fl	   and	   IL-­‐15-­‐/-­‐	  mice	   compared	   to	  Ncr1greenCre	   control	  mice	   at	   the	   same	  time	   point	   (day	   10)	   (Fig.	   5B).	   This	   increase	   in	   T	   cells	   was	   due	   to	   the	   presence	   of	  significantly	  more	  of	  CD4+,	  but	  not	  CD8+	  T	  cells	  (Fig.	  5C).	  These	  CD4	  T	  cells	  from	  tumor	  bearing	  Ncr1greenCreIl2rgfl/fl	  had	  an	  activated	  effector	  phenotype	  in	  contrast	  to	  those	  from	  tumor-­‐bearing	  control	  mice	   (Fig.	  5D).	  Most	   lung	  CD8	  T	  cells	   from	  all	  mice	  displayed	  a	  naïve	  phenotype	  (Fig.	  5E).	  We	  did	  not	  observe	  any	  statistically	  significant	  differences	  in	  splenic	  “CD4+”	  or	  “CD8+	  T-­‐cell”	  numbers	  or	  phenotypes	  in	  the	  different	  mice	  (Supporting	  Information	   Fig.	   6).	   The	   increase	   of	   CD4+	   T	   cells	   in	   lungs	   of	   tumor-­‐bearing	  mice	  was	  paralleled	  by	  an	   increase	   in	  CD19+	  B	  cells	   (Fig.	  5B).	  Together,	  our	  data	  provide	  strong	  evidence	   that	   NK	   cells	   are	   crucially	   involved	   in	   the	   anti-­‐B16	   immune	   response	   and	  suggest	  NK	  cell	  are	  involved	  in	  the	  regulation	  of	  the	  adaptive	  immune	  response	  in	  this	  tumor	  model.	  
Discussion	  	   Here	  we	  report	  the	  generation	  of	  a	  novel	  transgenic	  mouse	  line	  for	  the	  study	  of	  gene	   ablation	   in	   NK	   cells.	   Ncr1greenCre	   mice	   express	   an	   EGFPcre	   fusion	   transgene	   in	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NKp46+	   cells	   from	   all	   organs.	   This	   mouse	   line	   differs	   from	   previously	   reported	  respective	  BAC-­‐	  and	  Knock-­‐in	  based	  NK-­‐Cre	  mice	   [15],[16]	   in	   that	   it	  uses	  only	  a	  short	  proximal	   promoter	   fragment	   derived	   from	   the	   C57BL/6	   background	   directing	   the	  expression	  of	  an	  EGFPcre	   fusion	  to	  NKp46+	  cells.	  The	  use	  of	  an	  EGFPcre	   fusion	  permits	  the	  direct	  detection	  of	  Cre-­‐expressing	  NK	  cells	  by	  FACS	  or	  histological	  analyses.	  	  	   Our	  data	  demonstrate	  that	  Ncr1greenCre	  mice	  efficiently	  delete	  loxP-­‐flanked	  target	  genes	   in	   NKp46+	   cells.	   Using	   Ncr1greenCreIl2rgfl/fl	   mice,	   we	   assessed	   the	   role	   for	   γc	  cytokine	   signaling	   in	   NK	   cell	   development.	   GFP	   expressing	   NKp46+	   cells	   were	   not	  detected	   in	   any	   tissue	   of	   these	   mice,	   demonstrating	   a	   γc	   cytokine-­‐dependency	   at	   the	  earliest	   stages	   of	  NK	   cell	   development	  when	   iNK	   cells	   begin	   to	   express	  NKp46.	  These	  results	   complement	   observations	   made	   in	   germ-­‐line	   γc-­‐deficient	   mice	   and	   in	   mice	   in	  which	   γc	   was	   conditionally	   deleted	   in	   mature	   lymphocytes	   using	   an	   inducible	   MxCre	  approach	   [33]–[35].	   Moreover,	   Ncr1greenCreIl2rgfl/fl	   mice	   demonstrate	   that	   all	   NKp46+	  cells	  depend	  on	  γc	  for	  their	  homeostasis,	  including	  classical	  as	  well	  as	  tissue-­‐resident	  NK	  cells,	   non-­‐NK	   ILC1s,	   and	   NCR+	  ILC3.	   Intra-­‐epithelial	   ILC1	   are	   CD3-­‐NK1.1+NKp46+	   cells	  that	  express	  high	   levels	  of	  CD160	  and	  appeared	  to	  be	   less	  dependent	  on	  IL-­‐15Rα	   than	  splenic	  NK	  cells	  [24].	  Moreover,	   the	  majority	  of	   IEL	  ILC1	  were	  shown	  to	  derive	  from	  a	  precursor	   that	   transiently	  expresses	  an	  EGFPcre	   fusion	   transgene	  under	   the	  control	  of	  the	   PLZF	   promoter;	   in	   contrast	   less	   than	   20%	   of	   splenic	   NK	   cells	   derive	   from	   PLFZ+	  precursor	  cells	   [36].	  The	   fact	   that	  both	   intra-­‐epithelial	   ILC1	  and	  splenic	  NK	  cells	  were	  strongly	  dependent	  on	  Il2rg	  suggests	  that	  at	  least	  one	  γc-­‐dependent	  cytokine	  (other	  than	  IL-­‐15)	  is	  implicated	  in	  intra-­‐epithelial	  ILC1	  homeostasis.	  	   We	   found	   that	   genetic	   deletion	   of	   NK	   cells	   is	   more	   specific	   than	   antibody-­‐mediated	  deletion.	  While	  anti-­‐NK1.1	  antibodies	  efficiently	  removes	  NK	  cells	  in	  B6	  mice,	  this	   treatment	   also	   removes	   NKT	   cells	   to	   varying	   degrees,	   at	   least	   from	   spleens	   and	  livers.	  This	  NKT	  cell	   effect	   should	  be	   taken	   into	  account	  when	  using	   this	  approach	   for	  studying	  NK	  cell	  functions	  in	  vivo.	  	  Diversity	  in	  the	  NK	  cell	  lineage	  generally	  refers	  to	  the	  presence	  of	  phenotypically	  and	  functionally	  distinct	  subsets	  of	  peripheral	  NK	  cells.	  The	  fact	  that	  tissue-­‐specific	  NK	  cell	   populations	  with	   unique	   transcription	   factor	   requirements	   for	   their	   development	  have	  been	  described	  in	  liver	  [21]–[23],	  thymus	  [37],	  skin	  and	  uterus	  [23],	  suggests	  that	  part	  of	  the	  observed	  diversity	  might	  be	  due	  to	  the	  presence	  of	  separate	  NK	  cell	  lineages.	  However,	  more	  recent	  data	  suggest	  that	  these	  tissue-­‐resident	  NK	  cells	  might	  be	  related	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to	   non-­‐NK	   ILC1	   sharing	   with	   NK	   cells	   some	   phenotypic	   features	   (NKp46	   and	   NK1.1	  expression)	  while	  lacking	  others	  (expression	  of	  NK	  cell	  markers	  like	  Ly49	  molecules	  and	  DX5)	   [24],[25].	   Further	   analyses	   are	   needed	   to	   clarify	   the	   relationships	   among	   these	  ILC1	   subsets	   and	   whether	   or	   not	   other	   ILC1	   subsets	   exist.	   Tissue-­‐resident	   NK	   cells	  appear	   to	   have	   functional	   capacities	   that	   differ	   from	   NK	   cells	   when	   assayed	   in	   vitro	  [21]–[23],[37].	  Whether	   tissue-­‐resident	   NK	   cells	   possess	   unique	   functionally	   relevant	  roles	  in	  immune	  responses	  in	  vivo	  is	  not	  fully	  understood.	  Similar	  to	  ILC2	  and	  3	  subsets,	  tissue-­‐resident	   NK	   cells	   may	   be	   involved	   in	   tissue	   homeostasis	   or	   remodeling	   rather	  than	  target	  cell	  recognition	  and	  destruction.	  Such	  a	  role	  has	  been	  suggested	  for	  decidua	  NK	  cells	   in	  the	  uterus	  (reviewed	  in	  [38]).	  The	  poor	  secretion	  of	  IFN-­‐γ	  by	  DX5-­‐	   liver	  NK	  cells	  upon	  stimulation	  in	  vitro	  or	  their	  reduced	  capacity	  to	  degranulate	  upon	  stimulation	  [21]	  contrasts	  with	  DX5+	  NK	  cells	   in	   the	   liver	  and	  elsewhere.	  Moreover,	  DX5-­‐	   liver	  NK	  cells	   were	   shown	   to	   produce	   a	   different	   cytokine	   profile	   compared	   to	   DX5+	   NK	   cells	  following	   stimulation	   [21]–[23]	   suggesting	   that	   these	   subsets	   might	   have	  complementary	  functions	  during	  immune	  response.	  Alternatively,	  each	  NK	  cell	   lineage,	  or	   more	   generally	   each	   ILC1	   subset,	   might	   have	   unique	   triggers.	   A	   comprehensive	  assessment	  of	  the	  functional	  capacities	  of	  the	  diverse	  ILC1	  subsets	  and	  the	  signals	  that	  activate	  them	  would	  help	  to	  distinguish	  between	  these	  possibilities.	  	  	   Ample	  evidence	  suggests	  that	  NK	  cells	  are	  important	  for	  the	  immune	  response	  to	  B16	   melanoma	   [15],[39]–[41].	   In	   humans	   and	   mice,	   primary	   melanomas	   as	   well	   as	  melanoma	  derived	  cell	  lines	  have	  been	  shown	  to	  express	  ligands	  for	  NKp46	  and	  DNAM1	  explaining	  their	  susceptibility	  to	  NK	  cell	  mediated	  lysis	  [39].	  However,	  more	  recent	  data	  suggest	  that	  the	  ability	  of	  NK	  cells	  to	  lyse	  B16	  cells	  might	  differ	  depending	  on	  the	  tissue	  of	  origin	  of	  the	  effector	  cells	  [42].	  This	  might	  in	  part	  be	  due	  to	  differences	  in	  accessory	  cells	  within	   tissues	   [42],[43].	  Experimental	  procedures	  aiming	  at	   the	  study	  of	  NK	  cells	  usually	  either	   involve	   the	  depletion	  of	  NK	  cells	  using	  monoclonal	  antibodies,	   like	  anti-­‐NK1.1	  or	  anti-­‐asialo-­‐GM1,	  both	  of	  which	  are	  not	  NK	  cell-­‐specific	  but	  deplete	  also	  subsets	  of	  T	  cells,	  or	  the	  use	  of	  immune-­‐deficient	  mice,	  like	  Rag2-­‐/-­‐γc-­‐/-­‐	  mice	  that	  lack	  not	  only	  NK	  cells,	  but	  also	  other	  ILC	  lineages	  as	  well	  as	  B	  and	  T	  cells,	  and	  display	  defects	  in	  lymphoid	  tissues,	   like	   lymph	   nodes	   and	   Peyer’s	   Patches	   [44].	   Moreover,	   recent	   reports	   have	  underscored	   the	   importance	   of	   the	   reciprocal	   cross-­‐talk	   between	   NK	   cells	   and	   other	  innate	   and	   adaptive	   immune	   cells	   for	   regulating	   immune	   responses	   [9],[10].	   Thus,	   it	  would	  appear	  important	  to	  preserve	  an	  intact	  environment	  when	  assessing	  the	  roles	  for	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NK	  cells	  in	  immune	  responses.	  The	  use	  of	  Cre-­‐technology	  has	  allowed	  several	  groups	  to	  generate	   mice	   lacking	   specifically	   NKp46+	   cells	   by	   deleting	   essential	   genes	   of	   the	   γc-­‐	  JAK3-­‐STAT5	  signaling	  axis,	  (γc	  this	  paper,	  and	  STAT5	  [15])	  and	  to	  probe	  the	  role	  of	  these	  cells	   in	   anti-­‐tumor	   responses.	   Both	   of	   these	  NK	   cell-­‐deficient	  mice	  display	   a	   profound	  defect	   in	   controlling	  B16	   lung	  metastases	   (this	   paper	   and	   [15])	   and	   together	   reveal	   a	  specific	  and	  essential	  role	  of	  NK	  cells	  in	  the	  anti-­‐B16	  immune	  response.	  	  	   Moreover,	   we	   demonstrate	   that	   the	   absence	   of	   NK	   cells	   during	   the	   anti-­‐B16	  immune	   response	   seems	   to	   be	   inversely	   correlated	   with	   the	   tumor	   load	   and	   the	  numbers	   of	   CD4+	   T	   and	  CD19+	   cells,	   respectively,	   in	   the	   lungs	   of	   tumor	   bearing	  mice.	  While	  NK	  cell-­‐mediated	  lysis	  of	  B16	  target	  cells	  could	  help	  release	  tumor	  antigens	  and	  potentially	  induce	  and/or	  enhance	  anti-­‐tumor	  T-­‐cell	  responses,	  our	  results	  suggest	  that	  NK	   cells	   might	   have,	   in	   addition,	   an	   immunoregulatory	   function	   during	   the	   anti-­‐melanoma	   immune	  response	  by	  restricting	   the	  numbers	  of	  CD4	  T	  and	  CD19	  B	  cells.	  A	  similar	   immunoregulatory	   role	   of	   NK	   cells	   has	   been	   demonstrated	   in	   several	   viral	  infection	  models	  [45].	  During	  infections	  of	  mice	  with	  intermediate	  doses	  of	  LCMV	  clone	  13,	  T	   cells	   control	   the	  virus	  but	   are	   inhibited	  by	  NK	   cells,	  while	   at	  high	  dose	  NK	   cells	  prevent	   a	   detrimental	   T	   cell	   response	   by	   killing	   proliferating	   CD4	   T	   cells	   resulting	   in	  persistent	   infections	  [45].	  Whether	  or	  not	  NK	  cells	  affect	  CD4	  T	  cells	  numbers	  directly	  (e.g.,	  via	  direct	  cytotoxicity),	  or	  indirectly	  (via	  targeting	  DCs),	  and	  whether	  the	  observed	  accumulation	  of	  B	  cell	  is	  due	  to	  lack	  of	  direct	  regulation	  by	  NK	  cells	  or	  a	  consequence	  of	  increased	  CD4	  T	  cell	  numbers	  in	  our	  model	  remains	  elusive.	  Unfortunately,	  the	  antigen	  specificity	  of	  the	  tumor-­‐infiltrating	  CD4	  T	  cells	  cannot	  be	  assessed	  owing	  to	  the	  lack	  of	  MHC	  class	  II	  specific	  B16-­‐peptides.	  That	  CD4	  T	  cells	  in	  the	  lungs	  of	  tumor	  bearing	  IL-­‐15-­‐/-­‐	  mice	  do	  not	  appear	  to	  be	  activated	  in	  contrast	  to	  those	  from	  Ncr1greenCreIl2rgfl/fl	  mice	  relates	  probably	  to	  the	  recently	  observed	  role	  of	  IL-­‐15	  in	  the	  expansion	  of	  these	  cells	  via	  inhibition	   of	   suppressive	   CD25+	   Treg	   cells	   [46],	   a	   mechanism	   unrelated	   to	   NK	   cells	  underscoring	   the	   importance	   of	   an	   intact	   microenvironment	   when	   studying	   gene	  functions	  for	  a	  specific	  cell	  type.	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Materials	  and	  methods	  
	  
Cloning.	  	   Ncr1greenCre	   was	   cloned	   using	   overhang-­‐extension	   PCR.	   The	   vectors	   pIGCN21	  containing	   the	   EGFPcre,	   and	   pL452	   containing	   bGHpA	   were	   obtained	   from	   Neal	  Copeland’s	   laboratory	   at	   the	   National	   Cancer	   Institute.	   3	   primer	   pairs	   were	   used	   to	  amplify:	   a)	   a	   626bp	   fragment	   of	   the	  murine	   Ncr1	   promoter	   (including	   the	   ATG	   start	  codon)	  and	  carrying	  at	  3’	  a	  21-­‐bp	  overlap	  complementary	  to	  the	  5’	  sequence	  of	  EGFPcre	  from	  the	  pIGCN21	  vector	  using	  primers	  1	  (5’-­‐	  GATTGAGAGACCCTGCCTCAGTG-­‐3’)	  and	  2	  (5’-­‐CAGCTCCTCGCCCTTGCTCACCATACCAGTGGCCAGACCAGTGCTGAAC-­‐3’),	   b)	   the	  
EGFPcre	   including	   at	   5’	   a	   28-­‐bp	   overlap	   to	   the	   3’	   sequence	   of	   the	   Ncr1	   promoter	  fragment	  and	  at	  3’	  a	  20-­‐bp	  overlap	  to	  the	  5’	  region	  of	  bGHpA	  site	  from	  the	  pL452	  vector	  using	   primers	   inv2	   (5’-­‐	  GTTCAGCACTGGTCTGGCCACTGGTATGGTGAGCAAGGGCGAGGAGCTG-­‐3)	   and	   3	   (5’-­‐	  CTAGAGAATTGATCCCCTCAAAGCTGATCAGTTATCTAGATCC-­‐3’),	   and	   c)	   a	   fragment	  containing	  the	  bGHpA	  site	  from	  vector	  pL452	  containing	  at	  5’	  a	  23-­‐bp	  overlap	  to	  the	  3’	  region	   of	   	   the	   EGFPcre	   using	   primers	   inverse	   3	   (5’-­‐	  GGATCTAGATAACTGATCAGCTTTGAGGGGATCAATTCTCTAG-­‐3’)	   and	   4	   (5’-­‐	  TAAGGGTTCCGCAAGCTCTAGTCG-­‐3’).	   Subsequently,	   fragments	   “a”	   and	   “b”	  were	   joined	  using	  overhang	  extension	  PCR	  as	  were	  fragments	  “b”	  and	  “c”.	  Finally,	  the	  fragments	  “a>b”	  and	   “b>c”	  were	   joined	  using	   overhang	   extension	  PCR.	  The	   resulting	   “a>b>c”	   fragment	  was	   cloned	   into	   the	  pCR-­‐Topo-­‐XL	  vector	   (Lifetechnologies).	  All	  PCRs	  were	  done	  using	  Phusion	  high	  fidelity	  DNA	  polymerase	  (Finnzymes).	  The	  final	  construct	  was	  sequenced	  and	   an	   error-­‐free	  DNA	  was	  purified	   and	   injected	   into	  C57BL/6	  pro-­‐nuclei.	  Ncr1greenCre	  mice	   were	   born	   at	   the	   expected	   Mendelian	   ratio	   were	   fertile	   and	   showed	   no	   gross	  developmental	   anomaly.	   In	   a	   fraction	   of	   offspring	   of	  Ncr1greenCre	  mice	   crossed	   to	  mice	  carrying	  a	   floxed	   target	   gene,	  we	  detected	  a	  partial	   or	   complete	  deletion	  of	   the	   target	  gene	   in	  DNA	   from	   tail	   biopsies	   suggesting	   that	   the	   recombination	   had	   occurred	   at	   an	  early	   developmental	   stage.	   Such	   germ-­‐line	   deleted	   mice	   were	   excluded	   from	   our	  analysis.	  	  
Mice	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Il-­‐15-­‐/-­‐,	   IL2rgfl/fl	   and	   ROSA-­‐tdRFP	   mice	   have	   been	   described	   previously	  [12],[19],[31],[34].	   IL2rgfl/fl	   and	   IL2rgfl/y	   are	   termed	   IL2rgfl/fl	   mice	   for	   simplification.	  Mice	  were	  bred	  in	  pathogen-­‐free	  breeding	  at	  the	  Central	  Animal	  Facilities	  of	  the	  Pasteur	  Institute	  (Paris,	  France)	  and	  were	  used	  between	  8	  to	  16	  weeks	  of	  age.	  All	  protocols	  for	  animal	   experiments	   were	   reviewed	   and	   approved	   by	   an	   ethics	   committee,	   and	   were	  done	  in	  accordance	  with	  national	   laws	  and	  institutional	  guidelines	  for	  animal	  care	  and	  use.	  	  	  
Cell	  preparation	  Mice	  were	   sacrificed	  by	  CO2	   asphyxiation	   and	   subsequent	   cervical	   dislocation.	   Spleen,	  LNs	   (mesenteric,	   inguinal,	   axillary,	   cervical)	   and	   thymus	   were	   removed	   and	   mashed	  through	  a	  100	  μm	  cell	  strainer	  (Falcon).	  T	  cells	  (using	  CD4	  and	  CD8	  microbeads)	  and	  B	  cells	   (using	   CD19	  microbeads)	  were	   depleted	   from	   thymocytes	   in	   order	   to	   enrich	   for	  thymic	  NK	  cells	  using	  MACS	  (Miltenyi).	  Bone	  marrow	  cells	  suspensions	  were	  obtained	  by	  flushing	  femurs.	  Red	  blood	  cells	  were	  lysed	  using	  the	  Red	  blood	  cells	  buffer	  (Sigma).	  Livers	  were	  perfused	  using	  PBS,	  cut	  into	  pieces	  and	  mashed	  through	  a	  metal	  100μm	  cell	  strainer.	   Single	   cell	   suspensions	   from	   lungs,	   liver,	   (shaved)	   skin,	   pancreas,	   salivary	  glands,	   and	   intestines	  were	  prepared	  using	   collagenase	  digestion	   and	  debris	   removed	  using	  Percoll	  gradients	  (GE	  Healthcare).	  	  
Flow	  cytometry	  Freshly	   isolated	   cells	   were	   treated	   with	   Fc-­‐Block	   (2.4G2;	   BioXCell).	   Monoclonal	  antibodies	  to	   the	   following	  mouse	  antigen	  were	  conjugated	  to	  Phycoerythrin	  (PE),	  PE-­‐CF594,	   PE-­‐cyanin	   7	   (PE-­‐Cy7),	   Peridinin	   chlorophyll	   protein-­‐cyanine	   5.5,	  Allophycocyanin	   (APC)	   (or	  Alexa	   Fluor	   647),	   Alexa	   Fluor	   700,	  APC-­‐Cy7	   (or	  APC-­‐Alexa	  Fluor	  750,	  or	  APC-­‐eFluor780),	  Pacific	  Blue,	  V450,	  Brilliant	  Violet	  421,	  Quantum	  dots	  605,	  Brilliant	  Violet	  605,	  Brilliant	  Violet	  711:	  CD3	  (145-­‐2C11),	  CD19	  (1D3),	  NK1.1	  (PK136),	  CD4	  (L3T4),	  CD8a	  (53-­‐6.7),	  CD94	  (18d3),	  CD127	  (A7R34),	  DX5	  (DX5),	  CD49a	  (HMa1),	  Ly49A	   (JR9-­‐318),	   Ly49D	   (4E5),	   Ly49G	   (AT-­‐8),	   Ly49H	   (3D10),	   Ly49C/I	   (5E6),	   NKp46	  (29A1.4),	  CD27	  (LG.3A10),	  CD122	  (TM-­‐1),	  CD25	  (PC61),	  CD44	  (IM7),	  CD62L	  (MEL-­‐14),	  IFN-­‐γ (XMG1.2),	  Granzyme	  B	  (GB12).	  Antibodies	  were	  purchased	  from	  Becton	  Dickinson,	  eBioscience	  and	  Biolegend.	  Stained	  cells	  were	  acquired	  with	  a	  FACSCanto	  II,	  a	  Fortessa	  (Becton	  Dickinson),	  and	  data	  analysis	  performed	  using	  FlowJo	  software	  (Treestar).	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Cytokine	  production	  Fresh	   spleen	   cells	   were	   cultured	   in	   round-­‐bottomed	   microtiter	   plates	   and	   were	  stimulated	   for	  4	  h	  at	  37°C,	  5%	  CO2,	   in	  RPMI	  10%	  FCS	  supplemented	  with	  either	   IL-­‐15	  alone	   (10	   ng/ml,	   Peprotech),	   IL-­‐15	   +	   IL-­‐12	   (5	   ng/ml,	   Peprotech),	   IL-­‐15	   +	   IL-­‐18	   (100	  ng/ml,	  MBL)	  or	   IL-­‐15	  +	   IL-­‐12	  +	   IL-­‐18.	  BD	  Golgi	  STOP	   is	  added	  at	   the	  beginning	  of	   the	  stimulation.	  Cells	  were	  washed,	  stained	  for	  extracellular	  markers,	  then	  fixed	  (BD	  fixation	  kit),	   and	   then	  were	   stained	   intracellularly	  with	   phycoerythrin-­‐conjugated	  monoclonal	  antibody	  to	  Granzyme	  B	  and	  phycoerythrin-­‐cyanin	  7	  conjugated	  monoclonal	  antibody	  to	  IFN-­‐γ	  (Becton	  Dickinson).	  
	  
In	  vivo	  tumor	  measurement	  B16F10-­‐luc2+	   cells	   were	   from	   Caliper	   Life	   Sciences.	   B16F10-­‐luc2+	   cell	   lines	   were	  maintained	   in	   Dulbecco	   modified	   Eagle	   medium	   supplemented	   with	   10%	   heat-­‐inactivated	   FCS,	   100	   U/mL	   of	   penicillin-­‐streptomycin,	   2	   mM	   L-­‐glutamine,	   and	   5	   mM	  mercaptoethanol.	  Mice	  were	  injected	  intravenously	  with	  1	  x	  106	  B16F10-­‐Luc2+	  cells	  on	  day	   0.	   Mice	   were	   shaved,	   anesthetized	   and	   injected	   i.p.	   with	   30	   μg	   D-­‐luciferin	   (R&D	  Systems)	  to	  acquire	  bioluminescence	  (IVIS	  100,	  Caliper	  LifeSciences)	  at	  day	  3	  and	  7	  with	  settings	  of	  4	  minutes	  exposure	  time	  and	  large	  binning.	  At	  day	  10,	  mice	  were	  sacrificed,	  the	   lungs	   isolated,	   and	   measured	   ex	   vivo.	   Average	   radiance	  (photons/seconds/cm2/steradian)	   is	   used	   to	   determine	   the	   tumor	   load.	   Average	  radiance	  and	  area	  (cm2)	  were	  calculated	  using	  Living-­‐Image-­‐v3.2	  software.	  	  
Statistical	  analysis	  Statistical	  analysis	  was	  performed	  using	  two-­‐tailed	  Student’s	  t-­‐test.	  Data	  are	  expressed	  as	  mean	  +	  SEM	  and	  were	  analyzed	  with	  Prism	  software	  Version	  4	  (GraphPad).	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Figure	  legends	  	  
Figure	   1.	   Generation	   of	   Ncr1greenCre	   mice.	   (A)	   Schematic	   representation	   of	   the	  transgene	   used	   to	   generate	   Ncr1greenCre	  mice.	   (B)	   Flow	   cytometric	   analysis	   of	   NKp46+	  versus	   GFP	   expression	   in	   CD3-­‐NK1.1+	   NK	   cells	   in	   the	   BM,	   spleen,	   liver	   and	   lungs	   of	  Ncr1greenCre	  mice.	  The	  gating	  strategy	  used	  is	  shown.	  (C)	  Flow	  cytometric	  analysis	  of	  GFP	  expression	  in	  NK	  cells	  in	  the	  different	  organs	  analysed	  of	  Ncr1greenCre	  mice	  (black)	  versus	  C57BL/6	   WT	   mice	   (tinted).	   (D)	   (Left)	   NK1.1	   vs	   CD127	   expression	   on	   gated	   CD3-­‐NKp46+GFP+	   cells.	   NCR+	  ILC3	   (NKp46+	   NK1.1-­‐	   CD127+)	   and	   NK	   cells	   (NKp46+NK1.1+).	  (Right)	   GFP	   expression	   (histogram	   on	   the	   right)	   by	   gated	   CD3-­‐NKp46+NK1.1+CD127-­‐	  (orange),	   CD3-­‐NKp46+NK1.1+CD127+	   (blue),	   and	   CD3-­‐NKp46+NK1.1-­‐CD127+	   (green)	  cells.	  Cells	  were	  isolated	  from	  the	  small	  intestine	  lamina	  propria	  of	  Ncr1greenCre	  mice.	  (E)	  Flow	   cytometric	   analysis	   of	   GFP	   expression	   in	   T	   (CD3+),	   and	   B	   (CD19+)	   cells	   in	   the	  spleen	  of	  Ncr1greenCre	  mice	  (black;	  n=	  10)	  versus	  C57BL/6	  WT	  mice	  (tinted;	  n=4).	  	  Results	  are	   representative	  of	   four	   independent	   experiments,	  where	   at	   least	   one	  mouse/group	  was	  analyzed	  per	  experiment.	  	  
Figure	   2.	   Characterization	   of	   NK	   cells	   in	   Ncr1greenCre	   mice.	   (A)	   Flow	   cytometric	  analysis	   of	   GFP	   expression	   in	   NK	   cell	   populations	   in	   the	   BM	   of	   the	   indicated	   mice.	  Dotplots	  show	  CD49b	  (DX5)	  versus	  NK1.1	  expression	  on	  CD3-­‐CD19-­‐CD122+	  cells.	  Gated	  are	  NKP	   cells	   (orange),	   iNK	   cells	   (blue),	   and	  mNK	   cells	   (green).	   The	  histograms	   show	  GFP	   expression	   in	   the	   different	   populations	   according	   to	   this	   color	   code.	   (B)	   GFP	  expression	   in	   splenic	   NK	   cells	   from	   Ncr1GFP/+	   	   (left)	   and	   Ncr1greenCre	   mice	   (right).	   (C)	  Expression	   of	   CD27	   versus	   CD11b	   by	   splenocytes	   from	   the	   indicated	  mice	   (n=5).	   (D)	  Expression	  of	   the	   indicated	  markers	  by	  peripheral	  NK	  cells	   from	  C57BL/6	  (black	  bars,	  n=11),	   and	  GFP+	  NK	   cells	   from	  Ncr1GFP/+	  (white	  bars,	   n=7),	   and	  Ncr1greenCre	  mice	   (blue	  bars,	   n=10).	   Data	   are	   shown	   as	  mean	   +	   SEM.	   Two-­‐tailed	   t-­‐t	   was	   used	   to	   generate	   p-­‐values.	  *	  p≤0,05.	  (E)	  Total	  NK	  cells	  number	  in	  BM	  (left)	  and	  spleen	  (right)	  of	  C57BL/6	  mice	  (black	  bars,	  n=11),	  Ncr1GFP/+	  (white	  bars,	  n=5),	  and	  Ncr1greenCre	  (blue	  bars,	  n=15).	  Data	  are	  shown	  as	  mean	  +	  SEM.	  (F)	  Splenocytes	  were	  stimulated	  with	  IL-­‐12,	  and	  IL-­‐18,	  and	   then	   intracellular	   IFN-­‐γ	   protein	   (left),	   and	   granzyme	   B	   protein	   (right)	   were	  measured	  in	  NK	  cells	  from	  C57BL/6	  mice	  (black),	  in	  GFP+	  NK	  cells	  from	  Ncr1GFP/+	  (red),	  and	  Ncr1greenCre	  mice	  (blue).	  Unstimulated	  cells	  were	  used	  as	  control	  (shaded	  area).	  The	  
	   22	  
numbers	  in	  the	  dotplots	  and	  histograms	  indicate	  the	  frequencies	  of	  cells	  in	  the	  indicated	  gates.	   (A-­‐F)	   Results	   are	   representative	   of	   three	   to	   four	   independent	   experiments	  performed	  with	  similar	  results.	  	  	  
Figure	  3.	  Characterization	  of	  Cre	  function	  in	  Ncr1greenCreRosa-­‐dtRFP	  mice.	  (A)	  RFP	  expression	  by	  CD3-­‐CD19-­‐NKp46+	  cells	  from	  the	  BM,	  spleen,	  and	  liver	  of	  Ncr1greenCreRosa-­‐dtRFP	   mice	   (n=4).	   Dotplots	   on	   the	   left	   show	   CD19-­‐	   cells.	   Gating	   of	   NKp46+CD3-­‐	   is	  indicated.	  RFP	  expression	  in	  the	  gated	  cells	  is	  shown	  on	  the	  right	  (histograms).	  Numbers	  indicate	   the	   frequencies	   of	   RFP+	   cells	   among	   gated	   cells.	   (B)	   Histograms	   show	   RFP	  expression	   by	   total	   lymphocytes	   (left).	   NKp46	   expression	   of	   the	   gated	   RFP+	   cells	   is	  shown	  on	  the	  right.	  (C)	  RFP	  expression	  by	  T,	  B,	  NKT,	  and	  dendritic	  cells	  in	  the	  spleen	  of	  Ncr1greenCreRosa-­‐dtRFP	   mice	   (n=4).	   (A-­‐C)	   Results	   are	   representative	   of	   three	  independent	  experiments,	  where	  one	  to	  two	  mice	  were	  analyzed	  per	  experiment.	  	  
Figure	   4.	   Ablation	   of	   NK	   cells	   by	   generating	   Ncr1greenCreIl2rgfl/fl	   mice.	   	   (A)	  Quantification	   of	   NK	   cells	   in	   spleen,	   BM,	   liver,	   lungs,	   LN,	   and	   among	   IELs	   from	   small	  intestine	  of	  Ncr1greenCre	  (white	  bars,)	  and	  Ncr1greenCreIL2rgfl/fl	  mice	  (black	  bars).	  Data	  are	  shown	  as	  mean	  +	  SEM	   from	  9	  mice/genotype.	  Two-­‐tailed	  Student’s	   t-­‐test	  was	  used	   to	  generate	  p-­‐values.	  (B)	  NKp46	  versus	  GFP	  expression	  by	  CD3-­‐CD19-­‐NK1.1+	  cells	  in	  spleen,	  BM,	   liver,	   lungs,	   LN,	   and	   among	   IELs	   from	   small	   intestine	   of	   Ncr1greenCre	   and	  Ncr1greenCreIL2rgfl/fl	  mice	  (n=9).	  (C)	  FACS	  analysis	  of	  γc	  expression	  by	  GFP-­‐	  NK	  cells	  from	  Ncr1greenCreIL2rgfl/fl	   mice	   (orange;	   n=5),	   GFP-­‐	   (blue)	   and	   GFP+	   (green)	   NK	   cells	   from	  Ncr1greenCre	  mice	  (n=5).	   	   (D)	  CD27	  versus	  CD11b	  distribution	  by	   the	   indicated	  NK	  cells	  (GFP+	  or	  GFP-­‐)	  in	  spleen	  and	  lungs	  of	  Ncr1greenCre	  and	  Ncr1greenCreIL2rgfl/fl	  mice	  (n=4).	  (E)	  Splenocytes	  were	  stimulated	  with	  IL-­‐12	  and	  IL-­‐18	  and	  4	  h	  later	  the	  intracellular	  level	  of	  IFN-­‐γ	  (left)	  and	  granzyme	  B	  (right)	  expressed	  by	  GFP-­‐	  NK	  cells	  from	  Ncr1greenCreIL2rgfl/fl	  mice	  (orange;	  n=10),	  and	  GFP-­‐	  (blue),	  as	  well	  as	  GFP+	  (green).	  NK	  cells	  from	  Ncr1greenCre	  mice	  (n=10)	  measured.	  (A-­‐E)	  Results	  are	  representative	  of	  three	  to	  seven	  independent	  experiments	  with	  at	  least	  one	  mouse	  per	  genotype.	  	  	  
Figure	   5.	   Anti-­‐tumor	   response	   in	   Ncr1greenCreIl2rgfl/fl	   mice.	   (A)	   Tumor	   growth	  analysis	  via	  bioluminescence	  detection	  in	  Ncr1greenCre	  (white),	  Ncr1greenCreIL2rgfl/fl	  (black)	  
	   23	  
and	  IL-­‐15-­‐/-­‐	  (grey)	  mice	  at	  day	  3,	  and	  7:	  pictures,	  average	  radiance	  and	  ex	  vivo	  analysis	  at	  day	  10.	  Data	  are	  shown	  as	  mean	  +	  SEM	  from	  5	  -­‐	  10	  mice/genotype,	  and	  are	  pooled	  from	  five	  independent	  experiments.	  (B)	  “NK-­‐“,	  “T-­‐“	  and	  “B-­‐cell”	  numbers	  in	  the	  lungs	  at	  day	   10	   of	   Ncr1greenCre	   (white),	   Ncr1greenCreIL2rgfl/fl	   (black)	   and	   IL-­‐15-­‐/-­‐	   (grey)	   mice.	   (C)	  “CD4+”	   and	   “CD8+	   T-­‐cell”	   numbers	   in	   the	   lungs	   at	   day	   10	   of	   Ncr1greenCre	   (white),	  Ncr1greenCreIL2rgfl/fl	   (black)	   and	   IL-­‐15-­‐/-­‐	  (grey)	  mice.	   (D)	   Phenotypic	   analysis	   of	   CD4+	   T	  cells	   in	   the	   lungs	   at	   day	   10	   of	   Ncr1greenCre,	   Ncr1greenCreIL2rgfl/fl	   and	   IL-­‐15-­‐/-­‐	   mice.	   (E)	  Phenotypic	   analysis	   of	   CD8+	   T	   cells	   in	   the	   lungs	   at	   day	   10	   of	   Ncr1greenCre,	  Ncr1greenCreIL2rgfl/fl	   and	   IL15-­‐/-­‐	   mice.	   (B-­‐E)	   Data	   derived	   from	   7-­‐14	   mice/genotype	  pooled	  from	  five	  independent	  experiments.	  	  (B,	  C)	  Data	  are	  shown	  as	  mean	  +	  SEM.	  Two-­‐tailed	  Student’s	  t-­‐test	  was	  used	  to	  generate	  p-­‐values.	  *	  p≤0.05,	  **	  p	  ≤0.005,	  ***	  p≤0.0005.	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  Information	  
Figure	  S1:	  Gating	  strategy	  and	  frequencies	  of	  GFP	  positive	  cells	  among	  NK	  cells	  from	  various	  organs.	  
Figure	  S2:	  Detection	  of	  GFP	  expressing	  cells	  in	  histological	  analyses	  of	  lymph	  nodes	  from	  Ncr1greenCre	  and	  Ncr1GFP/+	  mice.	  
Figure	  S3:	  Frequency	  of	  RFP	  expressing	  cells	  among	  by	  GFP3	  CD3-­‐CD19-­‐NK1.1+NKp46+	  cells	  from	  Ncr1greenCre	  mice.	  
Figure	  S4:	  Quantification	  of	  CD3+CD19-­‐	  and	  CD19+CD3-­‐	  cells	  in	  various	  organs	  from	  Ncr1greenCre	  and	  Ncr1greenCre	  IL2rgfl/fl	  mice	  .	  
Figure	   S5:	   Depletion	   of	   NK	   and	   NKT	   cell	   via	   injection	   of	   anti-­‐NK1.1	   antibodies	   into	  C57BL/6	  mice.	  	  
Figure	  S6:	  Quantification	  and	  phenotype	  (CD44	  vs	  CD25,	  CD44	  vs	  CD62L)	  of	  splenic	  CD4	  and	  CD8	  T	  cells,	  respectively,	  of	  the	  indicated	  mice	  10	  days	  after	  tumor	  inoculation.	  
	  
	  	  






